These benefits, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the strategy of concentrating on ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Diseases. Conolidine promises being a innovative https://winstonb849meu4.slypage.com/profile